Dr. Cheryl M Ober, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3200 W Market St, #108, Fairlawn, OH 44333 Phone: 330-869-9911 Fax: 330-869-9780 |
Andrea R Steinberger, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2708 Crawfis Blvd, Fairlawn, OH 44333 Phone: 330-869-6673 Fax: 330-864-3270 |
Akron Hearing Health Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3200 W Market St Ste 108, Fairlawn, OH 44333 Phone: 330-869-9911 Fax: 330-869-9780 |
Angela E Damron, M.A., CCC/A Audiologist Medicare: Medicare Enrolled Practice Location: 3200 W Market St Ste 108, Fairlawn, OH 44333 Phone: 330-869-9911 |
Norin Hearing Services Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2640 W Market St, Suite 303, Fairlawn, OH 44333 Phone: 330-253-2221 Fax: 330-867-1748 |
Mrs. Helene S Norin, MA FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2640 W Market St, Suite 303, Fairlawn, OH 44333 Phone: 330-253-2221 Fax: 330-867-1748 |
Advanced Audiology Services Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3250 W Market St, Suite # 4, Fairlawn, OH 44333 Phone: 330-666-0619 |
Dr. Gina Stillitano, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3200 W Market St, Suite 108, Fairlawn, OH 44333 Phone: 330-869-9911 |
Mr. Mark S Norin, MA FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2640 W Market St, Suite 303, Fairlawn, OH 44333 Phone: 330-253-2221 Fax: 330-867-1748 |
News Archive
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICORĀ® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Most young adult women who regularly visit indoor tanning salons support the introduction of policies to make it safer, but are against a total ban. This is according to a study led by Darren Mays of Georgetown University Medical Center in the US, in the journal Translational Behavioral Medicine: Practice, Policy, Research, published by Springer.
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation (PE). These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.
Eisai announces today that Halaven (eribulin) will be marketed in selected countries within the Middle East region through a new partnership between Eisai EMEA (Europe, the Middle East, Africa, Russia and Oceania) and NewBridge Pharmaceuticals.
› Verified 7 days ago